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Background. In bipolar disorder (BD), seasonality of symptoms is common and disturbances in circadian
rhythms have been reported.
Objectives. We identified high-penetrance families in a geographically restricted area in Northern Fennoscandia
and studied the seasonal variation of clinical symptoms among BD subjects and their healthy relatives.
Design. We explored the clinical characteristics of subjects living in Northern Fennoscandia, with extreme
annual variation in daylight. Among known indigenous high-risk families for BD, we compared the affected
ones (N16) with their healthy relatives (N15), and also included 18 healthy non-related controls from the
same geographical area. Seasonal fluctuation in clinical measures was followed up at the 4 most demarcated
photoperiodic time points of the annual cycle: around the summer solstice and autumn equinox in 2013, the
winter solstice in 2013/2014, and the spring equinox in 2014. In the baseline, lifetime manic symptoms [Mood
Disorder Questionnaire (MDQ)] and morningnesseveningness questionnaire type (MEQ) were registered,
whereas in the follow-up, depressive [Beck Depression Inventory (BDI)] and distress [General Health
Questionnaire (GHQ-12)] symptoms and alcohol consumption and sleep were recorded.
Results. Possibly indicative or statistically significant differences in symptoms between the affected subjects and
their healthy relatives were the BDI winter (13.3 vs. 2.6, t2.51, p0.022) and spring scores (12.6 vs. 3.2,
t1.97, p0.063) and GHQ winter (4.2 vs. 0.82, t2.08, p0.052) and spring scores (3.8 vs. 0.82,
t1.97, p0.063). Scores were higher among the affected subjects, exceeding a possibly diagnostic threshold
(10 and 3) at all the time points, and without the notable seasonality which was observed among the healthy
relatives. In the overall population, MDQ and MEQ scores had an inverse correlation (0.384, significant at
0.016), indicating increased lifetime manic behaviour among ‘‘the night owl’’ chronotype subjects.
Conclusions. In an Arctic population sample, we found different seasonal fluctuation in mood and distress
symptoms and sleep duration scores between subjects with bipolar spectrum disorders and their healthy
relatives. Despite the relatively small sample size, the results indicate that the symptoms and signs of BD relate
to a disturbance in seasonal variation. Seasonal variation can be considered as an interesting endophenotype
for BD and a promising target for further genetic studies.
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B
ipolar disorder (BD) is a recurrent, episodic mood
disorder, characterized by alternating periods of
manic and depressive behaviour (1,2). Additional
subtypes of BD have been described, and certain other
psychiatric disorders have bipolarity of mood among
their core symptoms (3). These include cyclothymia and
schizoaffective disorder, which are considered to belong
to a wider spectrum of BDs (4,5).
According to population studies, the lifetime prevalence
of bipolar type I disorder is between 0.2 and 3.3% (6), and
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of the wider spectrum of BDs between 2.4 and 15.1% (7).
Epidemiological studies have previously reported regional
variation as well as some particularly high-penetrance
families in the distribution of BD in Finland (8,9). Genetic
and specific environmental factors have explained the
variance in illness liability, yielding a heritability estimate
range of 0.670.93 (10), and associations with some com-
mon risk variants have been reported (1113).
The role of environmental factors in the risk of onset
of BD remains more controversial (14,15). Stressful life-
events, substance abuse and sleep cycle disturbances are
known to precipitate individual mood episodes, although
the causality in these associations is probably reciprocal
and complex (16,17).
There is evidence for an increase in the incidence of
mood episodes as a result of rapid changes in exposure to
daylight, especially in northern areas (18) but also in other
parts of the world (19,20). Individuals with BD have been
reported to experience seasonality in symptoms (21), and
up to 2025.5% of bipolar patients may present with a
seasonal pattern (22,23). Circadian and seasonal rhythms
are often disturbed in BD, and changes in these rhythms
can induce mania (24,25). Current data indicate an in-
creased incidence of mania hospitalizations during the
spring season in northern Finland (Svirskis et al., manu-
script in preparation).
In northern parts of the world, seasonal variation in
mood and behaviour appears to be convergent with acti-
vities in social and occupational life. Annual fluctuation
in mood and social activity may have been adaptive in
Arctic areas, with variation in available food and other
resources according to seasons of the year (26,27). In
addition, circadian typology regarding the sleepwake
cycle indicates a tendency towards the ‘‘morning type’’
being more prevalent in the north (25).
The aim of this study was to explore the seasonal
variation associated with BD in northern latitudes, using
affected subjects and their relatives in families with multi-
ple cases of BD. We hypothesized that the strong annual
variation in external conditions in very northern latitudes
could have led to disturbed adaptation among the affected
subjects, possibly representing an etiological factor in the
disease process.
Present investigation
Subjects
We explored the clinical characteristics of 3 groups of
subjects living in extreme northern lighting conditions.
Group 1 consisted of subjects suffering from bipolar spec-
trum disorder in pedigrees with known high prevalence
of these disorders; Group 2 were healthy family controls
for the affected; and Group 3 were healthy non-related
controls living in the same geographical area. We investi-
gated the possible seasonal fluctuation in mood, distress,
sleep, social activity and alcohol consumption of subjects
in Groups 1 and 2 by monitoring these parameters during
a period of 1 year at the 4 most demarcated or extreme
seasonal time points, around the 2 solstices and equinoxes.
Baseline measurements and their correlations were made
for all 3 groups. As a specific feature of our setting, Groups
1 and 2 represented to a large extent the indigenous
population of the northern latitudes, the Sa´mi people,
who have settled the area for approximately 8,00010,000
years.
The Sa´mi people are the only indigenous people in
Europe. For the most part, they live in the northernmost
area of Scandinavia, including parts of Finland, Norway
and Sweden. Genetically, the Sa´mi people are a unique
population (28), which differs from other Scandinavians.
During their routine clinical work at a health centre, the
health-care professionals had observed a high incidence of
probable bipolar subjects in 3 Sa´mi family branches
(Families A, B and C) in northernmost Fennoscandia,
between latitudes 688N and 708N. Family A (N20)
included a family in which 4 out of 6 siblings had known,
diagnosed and lithium-treated BD type I, and bipolar
illness occurred in the same pedigree with a notably high
frequency. Similar observations held for another family
branch (family B, N8) as well as for a third family C
(N3) from the Sa´mi population (Fig. 1). In cases of
lack of hospitalization and consequent clinical diagnoses,
a structured clinical interview (SCID I) (29) and a set of
structured questionnaires about mental health symptoms
were used to obtain clinical diagnoses. Altogether, 16 sub-
jects with a bipolar spectrum disorder were identified in
the protocol. Healthy relatives (n15) were selected to
attend as family control subjects, and 18 non-related sub-
jects living in the same area and lighting conditions were
chosen as controls, particularly for further genetic studies.
Ethical issues
The research plan was reviewed and approved in The
Regional Ethics Committee of the Northern Ostrobothnia
Hospital District. The participants were informed in detail
about the objectives and proceedings of the study, and they
were allowed to withdraw at any point. They gave a written
informed consent regarding their participation. Their travel
expenses and a lunch voucher for the examination day
were reimbursed. As an additional benefit, the expertise
of the mental health professionals was at their dis-
posal in case of need for consultations or more general
information. The study process was reviewed and con-
sidered by the authors to follow the principles of the
WMA Helsinki Declaration.
The study periods
The clinical follow-up data and blood samples were col-
lected at Arctic latitudes during 3-week periods between
July 2013 and March 2014 during the 4 most demarcated
periods of light exposure of the year: the period of
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most light around midsummer (SUMMER, S1); the
period of the fastest decrease in light exposure around
SeptemberOctober (FALL, S2); the darkest period around
DecemberJanuary (WINTER, S3); and the most rapidly
increasing light period in MarchApril (SPRING, S4)
(Fig. 2).
Data collection
Among the subjects from Arctic high-risk families for
bipolar spectrum disorders (Groups 1 and 2), the initial
evaluation for psychiatric disorders and their symptoms
included a clinical interview, the Structured Clinical Inter-
view for Psychiatric Disorders (SCID I) (29), in addition
to patient record data. Furthermore, we evaluated their
baseline characteristics, including lifetime manic symp-
toms assessed with the Mood Disorder Questionnaire
(MDQ) (30,31), lifetime traumatic experiences assessed
with the Trauma Screening Questionnaire (TSQ) (32) and
the circadian preference for daily activities assessed with
the MorningnessEveningness Questionnaire (MEQ) (33).
In a follow-up at the same 4 time points, we collected
data on mood and distress as assessed with the Beck
Depression Inventory (BDI) (34) and the General Health
Questionnaire (GHQ-12) (35), questionnaire-based alcohol
consumption (grams per week) and a sleep duration ques-
tionnaire (hours per day).
The data collection was conducted by the local chief
medical practitioner, assisted by local community nurses
and a psychiatric resident, of which 1 community nurse
and the psychiatric resident had received formal training
for SCID  interviewing.
Statistical analyses
Due to the relatively small sample size, we also report
p-values from 0.1 to 0.05 as showing a probable tendency
to significance, in order not to miss any finding possibly
Fig. 2. Time points of data collection.
Fig. 1. Families A, B and C with bipolar subjects (black).
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indicative of a true difference. We used the bivariate
correlation test, the t-value for individual samples and
one-way ANOVA for testing the differences in clinical
measures at the baseline and at the different time points,
but we tested mainly the differences between affected
and healthy relatives in the identified pedigrees. We used
the General Linear Model test for repeated measures in
testing the variance in clinical measure scores within the
affected and the healthy subjects. IBM SPSS 23 software
was used for the analyses (35,36).
The results
Characteristics of the sample
The participants from the families did not differ signifi-
cantly between the affected and the healthy ones in their
age or sex (mean 59.9 years vs. 50.9 years, t1.35,
p0.189; M/F 60% vs. 75%, Fisher’s test, p0.458).
The majority of the affected (12/16) had BD type I, 1 had
BD type II, 2 had cyclothymia, and 1 had schizoaffective
disorder. Five of the 15 healthy relatives had some kind
of depressive disorder. The healthy non-related controls
had been collected via the health centre mainly for further
genetic controls and baseline information, and they were
not matched for age or sex: 89% of them were females and
mean age was 54.8 years. They were not interviewed for
clinical diagnoses.
The baseline scores and their associations
In baseline measurement, the subjects with a bipolar
spectrum disorder had the highest MDQ scores (9.0 vs.
2.5 vs. 1.0, F23.36, pB0.01), when compared with the
pedigree controls and non-related controls. Differences
in the TSQ and MEQ appeared to be statistically non-
significant for the 3 groups.
Correlations between the lifetime MDQ scores and
several clinical measures in the overall population includ-
ing the non-related controls are presented in Table I. The
MDQ and MEQ sum scores had an inverse correlation
(r0.384, P0.016), and the MDQ sum score corre-
lated positively with BDI and GHQ sum scores at the
follow-up.
Seasonal variation in symptoms among affected
subjects and their healthy relatives
At the follow-up, we measured the symptoms of depres-
sion (BDI) and distress (GHQ-12), sleep and alcohol use
between the subjects with a bipolar history and the non-
affected controls during 4 time points of the year. The
results are presented in Table II and Figure 3.
Possibly indicative or statistically significant differences
in symptoms between the affected and the healthy relatives
were the BDI winter (13.3 vs. 2.6, t2.51, p0.022,
Cohen’s d1.0712, h20.260) and spring scores (12.6 vs.
3.2, t1.97, p0.063; Cohen’s d0.8403, h20.163)
and GHQ winter (4.2 vs. 0.82, t2.08, p0.052,Ta
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Cohen’s d0.9024, h20.193) and spring scores (3.8 vs.
0.82, t1.97, p0.63, Cohen’s d0.8421,h20.170).
The affected had significantly more sleep in the fall
(9.3 vs. 7.3 h, t2.61, p0.017, Cohen’s d1.1522,
h20.232), and also in the spring. The affected had higher
BDI and GHQ scores at all times, exceeding the estab-
lished threshold values for possible depressive or anxious
states (BDI ten points and GHQ-12 three points) (35). The
BDI scores for the healthy relatives, but not for the
affected individuals, varied between the 4 time points
(GLM: F22.210, significant at 0.043 vs. F1.919,
significant at 0.303).
Discussion
In an Arctic population sample, we found different sea-
sonal fluctuation in mood and distress symptoms and
sleep duration scores between subjects with a bipolar
spectrum disorder and their healthy relatives. Although
the study sample is relatively small, the results suggest
that the manifestation of BD relates to a disturbance in
seasonal variation. It appears that, in families with multi-
ple cases of BDs and putatively with a high genetic risk,
those with the disorder have a distinct, possibly disturbed
pattern of seasonal fluctuation. The affected may have
lost a natural, season-syntonic variation in their general
activity, and they may be prone to a relative elevation
of depressive and distress symptoms during spring- and
summertime, with more daylight.
A marked difference between the affected indivi-
duals and their relatives in the seasonal assessments of
depressive and distress symptoms and sleep duration was
observed from time point to time point during the follow-
up. A relative winter and spring elevation of depressive
and distress symptoms among the affected is convergent
with the reported winter and spring activation of bipolar
spectrum disorders. In the families with multiple affected
individuals, those with the disorder phenotype expressed
continuing affective and distress symptoms from winter
to spring, whereas the symptom level of the non-affected
siblings decreased. Furthermore, these fluctuations in mood
and sleep were preceded by significant differences in the
level of alcohol intake in the autumn.
One finding deserves a closer look. First, the higher
the MDQ score was, the lower the MEQ score was. This
indicates that the closer to the ‘‘night owl’’ a subject’s chro-
notype was, the more likely were lifetime manic symptoms.
Our finding is original, and it agrees with earlier reports
that among ‘‘night owls’’ the probability of either type 1 or
type 2 BDs is increased (37,38), and that during a follow-
up of 4 years on average, patients with BD remain as
‘‘night owls’’ regardless of their prevailing mood state (39).
This is particularly interesting in the context of a general
increased prevalence of the morning type in northern
latitudes (25).
In general, the period from the winter solstice to the
spring equinox includes a gradual increase both in day
length and in social activation, with increasing mobility.
The lack of fluctuation in clinical symptoms could be seen
as a season dystonic pattern, and as a failure to adapt
to increase in external light and social activation. The
biological mechanisms will be an interesting focus for
Table II. Clinical variable scores in the follow-up points during the year
Group Measures
Summer 2013
Mean (SD)
Autumn 2013
Mean (SD)
Winter 2014
Mean (SD)
Spring 2014
Mean (SD)
Affected subjects (N16; M12, F 4) GHQ-12 3.67 (5.21) 3.55 (5.07) 4.22* (4.76) 3.80* (4.85)
MDQ: 8.96 (SD 4.06)** BDI 11.50 (11.67) 11.58 (11.04) 13.33** (13.78) 12.64 (15.47)
TSQ: 1.75 (SD 3.11) Alcohol consumption 161.17 (393.10) 474.35* (597.45) 168.61 (377.75) 343.59 (816.63)
MEQ: 49.20 (SD 4.13) Sleep hours 8.67 (2.64) 9.29 (2.14) 8.44* (1.69) 9.18** (1.89)
Healthy family controls (N15; M 9, F 6) GHQ-12 2.10 (3.03) 2.00 (2.36) 0.82* (1.25) 0.82* (1.25)
MDQ: 2.49 (SD 3.21)** BDI 6.50 (6.20) 6.70 (5.48) 2.64** (3.07) 3.18 (3.17)
TSQ: 0.67 (SD 1.61) Alcohol consumption 50.88 (61.74) 72.81* (88.98) 45.99 (62.72) 58.70 (70.12)
MEQ: 51.21 (SD 3.60) Sleep hours 8.25 (1.09) 7.32** (1.06) 7.41* (0.92) 7.60** (1.02)
MEQ: MorningnessEveningness Questionnaire; TSQ: Trauma Screening Questionnaire; MDQ: Mood Disorder Questionnaire;
BDI: Beck Depression Inventory; GHQ-12: General Health Questionnaire 12 items.
*pB0.01, between affected and healthy relatives (one-way ANOVA).
**pB0.05, between affected and healthy relatives (one-way ANOVA).
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
Summer 2013
solstice
Autumn 2013
equinox
Winter 2014
Solstice
Spring 2014
equinox
Chart Title
GHQ Affected BDI Affected GHQ Healthy BDI Healthy
Fig. 3. GHQ-12 and BDI symptom scores during the follow-up.
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future studies including analysis of variations in genetic
regulatory mechanisms during different seasons.
Some limitations should be noted. Due to the sparse
population in the study area, the sample in this work
was relatively small. The setting was built on observations
of certain pedigrees having a surprisingly high incidence
of bipolar spectrum disorders, and a hypothesis on the
seasonality of the phenotype was then to be tested by
clinical measures. Having only 16 vs. 15 subjects in the
pedigrees decreases the statistical significance of the find-
ings and leaves a possibility for both type 1 and type 2
statistical errors.
The third group, consisting of healthy non-related
subjects, were not age- or sex-matched with Groups 1 and
2, but rather they were mainly females. Therefore, their
clinical follow-up measures were incomparable with the
family subjects, and they were only used for validation of
the baseline measures (Table I).
As a strength, the attrition rate was high, and at least
1 DNA sample and baseline clinical data were obtained
from all the identified bipolar subjects. This most probably
indicates the community health centre team’s good moti-
vational skills and understanding of the local conditions.
Conclusions
According to our small sample study, the symptoms and
signs of BD in Arctic latitudes relate to a disturbance
in seasonal variation. Seasonal variation is an interesting
intermediate phenotype for BD and a promising target
for further genetic studies.
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